"This is a good example of how Recovery Act funds are accelerating the pace of research, in this case by enabling a multi-disciplinary collaboration that removes a roadblock to progress in an important area," said Jeremy M. Berg, PhD, director of the National Institute of General Medical Sciences. "By capitalizing on his collaborator's proteomic approach, Dr. Reichner could quickly generate new insights about how white blood cells respond to infection and injury, possibly leading to new strategies for developing immune-enhancing therapeutics."

The funding will also allow Reichner and Salomon to create a job opportunity for the study. Kebing Yu, PhD, a recent graduate from Brown, will join the research team. Reichner comments, "The ARRA funding is not only helping us to accelerate our research, but overall, it has a positive impact on the economy in Rhode Island as we continue to grow the research sector and establish new job opportunities." He adds, "We appreciate this funding from the ARRA and the NIH, who saw the value of our research and its potential implications."

Source: Lifespan